Browse by Tags

Axxent Brachytherapy System Recall-Device Released Particles of Tungsten Throughout Woman’s Breast During Treatment-Lawsuit

I can only imagine what the patient is going through after specifically waiting for this device to become available as a safe method of treating her breast cancer. This happened at Hoag Hospital in Orange County and luckily enough the particles...

Published Mon, Mar 03 2011 12:01 PM by The Medical Quack

Filed under: Medically Related, Technology, healthcare, Cancer, Breast Cancer, Hoag Hospital, radiation, recall, iCAD, shield, Axxent Brachytherapy System, FDA treatment, Xoft

Cytori Stem Cell Breast Reconstruction Study Shows The Process is Safe With Peer Review Later This Year-Regenerative Medicine

I started covering Cytori back in 2007 and if you do a search you can find plenty here at the Medical Quack to include the initial use in Europe and the fact that GE decided to invest and help commercialize. The system takes a women’s own...

Published Wed, Mar 03 2011 12:48 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, Cancer, clinical trials, GE, Stem Cells, Regenerative Medicine, heart attacks, Cytori, breast reconstruction, fat cells

Plexxikon Biotech Company Bought by Daiichi Sankyo for $935 Million

As you can see from the image below the company has a melanoma drug about ready to submit for on approval and they are working with Roche (Genentech) for the marketing. The skin cancer drug helps sustain life and is an oral medication taken. ...

Published Tue, Mar 03 2011 2:16 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Biotech, Cancer, FDA, Oncology, Doctors, Japan, melanoma, Mergers and Acquisitions, Daiichi Sankyo, Plexxikon

FDA Grants Genentech (Roche) a Hearing on Avastin ’s Use for Metastatic Breast Cancer

The date for the hearing is a few months off and until that time the drug is still approved as a first line treatment of the HER2 Negative mBC (breast cancer). Genentech filed the request for a formal hearing and the opportunity to present additional...

Published Fri, Feb 02 2011 2:57 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, health insurance, Claims, Cancer, Oncology, Breast Cancer, Roche, healthcare reform, Susan G. Komen, Avastic, FDA. Genentech

Study: Leave Robotic Prostatectomy in the Hands of Experts

By now most of us know about the daVinci robot that is used for prostate surgeries and this new study suggests that it may not be advisable for every smaller community hospital to perform the procedure but rather rely on the high volume centers of excellence...

Published Thu, Feb 02 2011 7:00 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Hospital, Surgery, Cancer, Doctors, robotic surgery DaVinci, experts, Prostatectomy

Sequencing The Genome of Prostate Cancer Tumors-Research To One Day Help Address Aggressive Versus Non Threatening

We normally think about sequencing our entire genome and with this study the genome of the tumor was used to compare against white blood cells from the patient. When you stop and think of all the data that has to be sifted through, it’s a lot. ...

Published Thu, Feb 02 2011 3:16 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Cancer, tumors, Prostate Cancer, Tumor, Prostate Cancer Foundation, Data, reserach and development, Seqencing

Study Shows Women Who Experience Hot Flashes May Have as High as a 50% Reduced Chance of Developing Breast Cancer

Well for once I feel lucky if this is true. Those bothersome irritating sessions of hot flushes are contributing to something good! Nobody likes to talk about this subject but for women it’s just a part of life and perhaps these flashes are burning...

Published Fri, Jan 01 2011 3:52 PM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, My Commentaries, healthcare, Hot Flashes, Cancer, Study, women's health, hormones, menopause, Hot Flash Havoc, Fred Hutchinson Cancer Research Center

FDA Audits Halted Duke University Clinical Trials Data Related to Genetic Cancer Predictors-A “Padded” Resume of Experience That Did Not Exist

The studies were carried out and then halted upon finding out that one of the biostatisticians lied about his background. Much of the published information on the trials has now been retracted and now the FDA is looking into the situation to get...

Published Fri, Jan 01 2011 2:46 PM by The Medical Quack

Filed under: Medically Related, Technology, Pharma/FDA News, healthcare, Cancer, FDA, clinical trials, Duke University, Journals, credentials, Cancer letter, ID

NHS-Health Secretary Submits Plan for Patients to Receive Chemotherapy at Local Retail Boots Store as Part of Reorganization

Boots is the equivalent in the UK of retail drug stores here in the US and they already offer additional options that we do not see in our drug store chains, such as dentistry services. This plan would call for patients to go to their nearest Boots...

Published Tue, Jan 01 2011 2:15 PM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, Medicine, UK, Physicians, Cancer, Hospitals, Budgets, NHS, Doctors, nurses, retail drug stores, healthcare reform, Boots

Amgen to Acquire BioVex, a Privately Held Biotechnology Company in Massachusetts

Just a couple weeks ago, Amgen contracted with Boehringer Ingelheim to take over their Fremont, California location so all employees will now report to Boehringer Ingelheim, which has it headquarters in Germany. BioVex is working on a new approach...

Published Tue, Jan 01 2011 3:52 AM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Pharma, Biotech, Cancer, clinical trials, Amgen, Vaccine, Mergers and Acquisitions, stock, transactions, head cancer, melinoma, BioVex, biotechnology

EPA-The Value of Life Terminology Proposes to Put More Value on Preventing Cancer Over Other Causes of Death-50%

The reason for this is due to the “scare” factor that comes along with cancer and and critics on the other side say this is not a good idea to tie into emotions for a value. What is used now is the “value of a statistical life” and at some point...

Published Mon, Jan 01 2011 7:55 PM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, healthcare, Cancer, Budgets, Algorithms, Risk, death, fear, statistics, screenings, EPA, value of life, mortality

Former FDA leader von Eschenbach Named to Viamet Board of Directors

Back in September of 2010 he was also names to the Board of another technology company that deals with urology and cancer therapies. Since his tenure at the FDA it sounds like von Eschenbach is returning to his roots with using his expertise in...

Published Wed, Jan 01 2011 1:23 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, Cancer, FDA, Prostate Cancer, Pharmaceuticals, National Cancer Institute, enzymes, Durham, Viamet Pharmaceuticals, drug discovery, Andrew von Eschenbach

Boehringer Ingelheim Buys Amgen Fremont, California Facility

Boehringer Ingelheim has been a contracted vendor for years for Amgen so the contracting just became a little larger today and employees now belong to Boehringer Ingelheim. Boehringer Ingelheim was also in the news last year with their FDA approval of...

Published Tue, Jan 01 2011 10:54 PM by The Medical Quack

Filed under: Medically Related, Pharma/FDA News, healthcare, Cancer, Amgen, Boehringer Ingelheim, resarch and development, FDA drugs

Arizona Company MedToGo To Begin Offering Transplant Tours to Mexico With Doctors Educated and Trained in the US

The company added the transplant services after Arizona stopped paying for several types of transplants. The company is located in Tempe, in the Phoenix area. The savings is quite large as we would expect. Joint replacements and lap...

Published Tue, Jan 01 2011 9:57 AM by The Medical Quack

Filed under: Medically Related, Other Items of Interest, Surgery, Cancer, Medical Tourism, Doctors, Transplants, Phoenix, Bone Marrow, MedToGo

Update on Physician Compare Sites-One MD Reader Found CMS to be More Accurate

The CMS system is not without errors and as mentioned, this is the first run at it but a physician reader did his comparison and shared his findings. He said in his area at least he didn’t find any “dead” or “retired” doctors on the list, so that...

Published Wed, Jan 01 2011 10:19 PM by The Medical Quack

Filed under: Medically Related, Technology, drugs, healthcare, medicare, medical billing, Cancer, Oncology, CMS, Fraud, Orange County, Health Insuance, American Cancer Society, Treatment, Glen Justice, AVVO

Syndication

Recent Posts

Tags

Archives